Scholarly Index
Dirk Elewaut
VIB-UGent Center for Inflammation Research; 22,464 total citations; 605 total publications; best world rank #47
VIB-UGent Center for Inflammation Research
22,464Total citations
605Total publications
76H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Spondyloarthritis Studies and Treatments | Lifetime | 47 | BE 2 | 99.32 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 165 | BE 2 | 98.53 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 329 | BE 6 | 98.59 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 221 | BE 5 | 98.52 |
| Inflammatory Bowel Disease | Lifetime | 581 | BE 18 | 97.59 |
| IL-33, ST2, and ILC Pathways | Lifetime | 495 | BE 9 | 95.56 |
| NF-κB Signaling Pathways | Lifetime | 601 | BE 16 | 95.00 |
| Bone and Joint Diseases | Lifetime | 955 | BE 20 | 93.75 |
| GDF15 and Related Biomarkers | Lifetime | 733 | BE 7 | 77.35 |
| Dupuytren's Contracture and Treatments | Lifetime | 908 | BE 26 | 67.66 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 57 | BE 2 | 98.07 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 201 | BE 5 | 95.18 |
| Bone and Joint Diseases | 2021-2025 | 195 | BE 6 | 89.60 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 346 | BE 4 | 92.26 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 817 | BE 12 | 89.16 |
| NF-κB Signaling Pathways | 2021-2025 | 460 | BE 10 | 51.48 |
| Musculoskeletal Disorders and Rehabilitation | 2021-2025 | 712 | BE 15 | 48.20 |